Conduit guiding tip

Information

  • Patent Grant
  • 10232142
  • Patent Number
    10,232,142
  • Date Filed
    Wednesday, June 10, 2015
    9 years ago
  • Date Issued
    Tuesday, March 19, 2019
    5 years ago
Abstract
A catheter tip for guiding the catheter through a patient's blood vessels and keeping the catheter in large vessels and preventing entry into smaller branch vessels.
Description
FIELD OF THE INVENTION

The invention generally relates to intravascular catheters, and more particularly to catheter tips for guiding the catheter through a patient's blood vessels during deployment.


BACKGROUND

Intravascular devices are devices that are generally placed within the lumen of a blood vessel during a therapeutic procedure. The therapeutic procedure may be any one of a wide variety of procedures, such as for example, stent delivery, angioplasty, atherectomy, embolic filtering, aortic occlusion, or any other therapeutic procedure performed in a blood vessel. The intravascular device used in such procedures typically include a catheter or guidewire for obtaining access to a desired location in a patient's blood vessel.


In general, the therapeutic procedures involve inserting a catheter or guidewire into a blood vessel such as the femoral artery. The catheter is then pushed into the blood vessel and into branches of blood vessels until the distal end of the catheter has reached a desired location within the patient's blood vessels. Once properly positioned, the therapeutic procedure is performed.


The path to the desired location in the patient's blood vessels is typically not an easy one. The blood vessels contain many branches into other blood vessels of varying sizes creating a tortuous path to almost any position in the body. Some applications use imaging to assist in properly placing the catheter. Radio opaque markers on strategic points on the catheter may be used to locate the parts of the catheter on an x-ray or other suitable form of imaging as the catheter is being placed. The use of imaging however requires special equipment often only available in specially equipped rooms in a hospital or other facility. There are intravascular procedures that may need to be performed on an emergency basis outside of a hospital setting. For example, a patient may require an aortic occlusion device to slow blood loss while at an accident site.


Even when a patient is in a hospital setting and requires a therapeutic procedure involving placing a catheter in the patient's blood vessels, it would be desirable to place the catheter without the need to use special imaging equipment. It would be desirable in some therapeutic procedures to have the option to administer a catheter from the patient's bedside without the need to transfer the patient to another room.


Another difficulty with placing a catheter is due to the construction of a typical catheter. Catheters typically extend distally to a tip. In some catheters, a guiding balloon near the tip is used to center the tip as the catheter winds its way through the tortuous path of the patient's blood vessels. Otherwise, the tip is pushed through the blood vessels without any real advantage for navigating the different branches that the catheter could follow.


There is a need in the art for a way to insert a catheter in a patient's blood vessels and to place the catheter at a desired location in the blood vessels without the need for special imaging equipment or for special facilities.


SUMMARY OF THE INVENTION

In view of the above, a device is provided for guiding a catheter through a patient's blood vessels. The device comprises a catheter guiding tip extending distally at a distal end of the catheter with an outer dimesion (sometimes referred to herein as “thickness”) substantially the same as an outer dimension of the catheter. The catheter guiding tip has at least one guiding member that expands distally to a tip portion having a shape in an uncompressed state that is larger than the catheter outer dimension along at least one axis perpendicular to a longitudinal axis of the catheter. The catheter guiding tip is deformable for insertion in a sheath larger than the tip portion when the tip portion is compressed but smaller than the tip portion when the tip porion is not compressed and is resilient for resuming the shape in the uncompressed shape when not subject to compression forces.


The methods, systems, and apparatuses are set forth in part in the description which follows, and in part will be obvious from the description, or can be learned by practice of the methods, apparatuses, and systems. The advantages of the methods, apparatuses, and systems will be realized and attained by means of the elements and combinations particularly pointed out in the appended claims. It is to be understood that both the foregoing general description and the following detailed description are exemplary and explanatory only and are not restrictive of the methods, apparatuses, and systems, as claimed.





BRIEF DESCRIPTION OF THE DRAWINGS

In the accompanying figures, like elements are identified by like reference numerals among the several preferred embodiments of the present invention.



FIG. 1 is a schematic drawing of an example of a catheter system.



FIGS. 2A-2G are different views of an example catheter guiding tip.



FIGS. 3A-3C are different views of another example catheter guiding tip.



FIGS. 4A-4C are different views of another example catheter guiding tip.



FIGS. 5A-5C are different views of another example catheter guiding tip.



FIGS. 6A-6C are different views of another example catheter guiding tip.



FIGS. 7A-7C are different views of another example catheter guiding tip.



FIGS. 8A-8C are different views of another example catheter guiding tip.



FIGS. 9A-9C are different views of another example catheter guiding tip.



FIGS. 10A-10C are different views of another example catheter guiding tip.



FIGS. 11A-11C are different views of another example catheter guiding tip.



FIGS. 12A-12C are different views of another example catheter guiding tip.



FIGS. 13A-13C are different views of another example catheter guiding tip.



FIGS. 14A-14C are different views of another example catheter guiding tip.



FIGS. 15A-15C are different views of another example catheter guiding tip.





DETAILED DESCRIPTION OF THE INVENTION

The foregoing and other features and advantages of the invention will become more apparent from the following detailed description of exemplary embodiments, read in conjunction with the accompanying drawings. The detailed description and drawings are merely illustrative of the invention rather than limiting, the scope of the invention being defined by the appended claims and equivalents thereof.


While the invention has been described in connection with various embodiments, it will be understood that the invention is capable of further modifications. This application is intended to cover any variations, uses or adaptations of the invention following, in general, the principles of the invention, and including such departures from the present disclosure as, within the known and customary practice within the art to which the invention pertains.


Furthermore, the invention is described in the context of a catheter system. It will be understood that the catheter guiding tips may be used with catheters for a variety of different therapeutic or diagnostic indications involving vascular interventions, including, for example and without limitation, vascular occlusion, angioplasty, stent delivery, artherectomy, drug delivery, imaging or the like. Applications of catheter systems in which embodiments of the invention find advantageous use may utilize any suitable access site, such as, for example, the femoral artery, the brachial artery, the subclavian artery, or any other suitable blood vessel. In addition, applications in which embodiments of the invention find advantageous use may also involve venous as well as arterial blood vessels.


In the following description, when reference is made to the terms “proximal” or “proximally” it is intended to mean a portion or component of the catheter system that is oriented away from the body into which the system is or is intended to be placed. Conversely, when reference is made to the terms “distal” or “distally” it is intended to mean a portion or component of the catheter system that is oriented toward the body into which the system is or is intended to be placed. Thus, for example, the catheter guiding tip described hereinafter is located at a distal end of the catheter system, while the proximal hub is located at a proximal end of the catheter system.



FIG. 1 is a schematic diagram of a catheter system 100 for performing an intravascular therapeutic procedure. The catheter system 100 comprises an intravascular device 102, a catheter member 104, a proximal hub 106, and a catheter guiding tip 108. The intravascular device 102 may be any mechanism, component, system or sub-system for performing a desired intravascular therapeutic procedure. Examples of the intravascular device 102 include, without limitation, a vascular occlusion device (e.g. occlusion balloon), an angioplasty device, a stent delivery system, an atherectomy system, a drug delivery system, an imaging system, an embolic filtering system, or the like.


The catheter member 104 may be any suitable wire, tube-like, or rod-like structure that may be fitted with the intravascular device 102 to extend into the patient's blood system, i.e., the patient's blood vessels, to position the intravascular device 102 at a desired location. The catheter member 104 may be made of a bio-compatible metal, such as a suitable metal alloy (e.g. nitinol) or stainless steel, or a bio-compatible polymer. The material of the catheter will typically be dictated by the therapeutic procedure, and on how long the catheter is to remain in the patient's blood vessels. The catheter member 104 may include one or more lumens that may be used, for example, to transport balloon filling fluids, to deliver drugs or other therapeutic materials such as thrombolyic agents, or to communicate with sensors.


The proximal hub 106 may be any suitable device for communicating between the proximal end of the catheter system 100 and the portions of the catheter in the blood vessels. The proximal hub 106 may include for example, ports or fittings (e.g. luer locks) for fluidly communicating with lumens in the catheter. In some examples, the proximal hub 106 may also provide a proximal endpoint or mechanisms (such as markings) for determining the positional extent of the catheter system 100 in the patient's blood vessels.


The catheter guiding tip 108 distally extends from a distal end of the catheter member 104 to a distal tip. The catheter guiding tip 108 extends from the catheter member 104 and expands distally to a tip portion. The tip portion has a shape in an uncompressed state that is larger than the catheter outer dimension along at least one axis perpendicular to a longitudinal axis of the catheter member 104. The catheter guiding tip 108 is deformable for insertion in a sheath during deployment and is resilient for resuming the shape in the uncompressed shape when not subject to compression forces.


The catheter guiding tip 108 may be an extension of the catheter member 104 and made of the same material as the catheter member 104. Alternatively, the catheter guiding tip 104 may be a component that is fixedly attached to a distal end of the catheter member 104. The catheter guiding tip 108 may have a shape and size in an uncompressed state that assists in guiding the catheter through the tortuous paths of the blood vessel. The catheter guiding tip 108 also has a shape that renders the tip atraumatic so as to prevent damage to the blood vessels during deployment.



FIGS. 2A-2G are different views of an example catheter guiding tip 200. The catheter guiding tip 200 comprises a tip portion 202 extending from a catheter member 204 at a connection point 203. As shown in FIG. 2C, which is a cross-sectional view at section A-A of FIG. 2B, the catheter member 204 has an outer dimension (thickness) T1 and the tip portion 202 extends from the connection point 203 at substantially the same outer dimension. The tip portion 202 extends to a transition section 208 where the tip portion 202 begins to transition from a solid or tubular generally or substantially cylindrical cross-section to a flattened solid or tubular cross-section at a coiled section 210. At the coiled section 210, the tip portion 202 has a shape in an uncompressed state with an outer dimension that is larger at T2 than the outer dimension T1 of the catheter along axis A, which is perpendicular to a longitudinal axis of the catheter member 204. The size T2 of the tip portion 202 in an uncompressed state is sufficiently large to prevent the tip portion 202 from entering smaller blood vessels as the catheter member 204 is inserted in the blood vessels.


The catheter member 204 may include a catheter lumen 222 as shown in FIG. 2C and in FIG. 2E, which is a cross-sectional view of the catheter member 204 at section B-B of FIG. 2B. The catheter member 204 may also include a catheter opening 220 in fluid communication with the lumen 222. The catheter opening 220 may be used to deliver drugs or thrombolytic agents through the catheter member 204 into the blood vessel. The catheter opening 220 may also be used for sensors or for any other function depending on the particular application of the catheter system. The tip portion 202 may be solid as shown at 232 in FIG. 2C and in FIG. 2F, which is a cross-sectional view of the tip portion 202 at section E-E in FIG. 2B. Alternatively, the tip portion 202 may be a hollow tube or tubular member. The tip portion 202 may include a narrowed portion at 230 that fits into the lumen 222 of the catheter member 204 at connection point 203. The tip portion 202 may be attached to the catheter member 204 by overmolding the tip portion 202 to the catheter member 204, or so that the tip portion 202 and the catheter member are thermally welded at 230 by any method. in some example implementations, the attachment may be accomplished by radio frequency energy applied to the tip portion 202 and the catheter member 204 at the location where they are joined, such as at the region of the connection point 203. Any other suitable method or equipment may be used for the connection between the tip portion 202 and the catheter 204. Thus, for further examples, other techniques include the use of laser welding, ultrasonic welding, a hot air nozzle or a hot jaw bonder, or a split die bonder could be used to make the thermal connection. In still other example implementations, an adhesive may be used to secure the bond between the tip portion 202 and catheter member 204.


The shape of the tip portion 202 of the catheter guiding tip 200 in FIGS. 2A-2G has a shape in an uncompressed state that is formed as a solid or tubular member extending distally, then flattens at transition section 208 to the flattened solid or tubular cross-section extending radially to form the coiled section 210 at an axis A that is perpendicular to the longitudinal axis of the catheter member 204. The coiled section 210 may hook circularly around such that a most distal point 206 of the tip portion 202 is positioned at or beyond a transition section 208 where the catheter 204 begins to flatten to the coiled section 210. This ensures that the most distal point 206 is somewhat tucked into the curl of the tip portion 202. If the most distal point 206 of the tip portion 202 does not extend to at least the transition point 208, it is possible that the most distal point 206 of the tip portion 202 may catch on something on the blood vessel wall (such as a stent, plaque, a dissection, or other devices) during extraction of the catheter. For example, in an example implementation in which the catheter system is deployed to apply a stent in a blood vessel, the tip portion 202 would be distal the location of the stent. During extraction after the stent has been placed in the blood vessel, the tip portion 202 would move past the stent. If the tip portion 202 were a simple hook in which the most distal point 206 only reaches part of the way around towards the transition point 208, there is a danger that the most distal point 206 of the tip portion 202 may catch on the stent as it moves past the stent during extraction of the catheter.


In the example shown in FIGS. 2A-2G, and particularly in FIG. 2G, the coiled section 210 has a solid or tubular flattened cross-section. FIG. 2G is an exemplary cross-section view of the coiled section 210 at section D-D when the tip portion 202 is a solid material. During deployment, the coiled section 210 is straightened for insertion into a sheath that is inserted into a blood vessel. Once the coiled section 210 is moved past the sheath and into the blood vessel, the coiled section 210 resumes its coiled shape. The flattened solid or tubular cross-section of the coiled section 210 permits the coiled section to resume its coiled shape so that the distal most point 206 is substantially aligned with the coiled section 210 and not skewed towards one side or the other.


In an example implementation of the tip portion 202 described with reference to FIGS. 2A-2G, the tip portion 202 may be made of an injection molded plastic material that is relatively supple so that the tip portion 202 may be compressed or deformed by extending the tip portion 202 along a longitudinal axis of the catheter member 204, yet resilient so as to resume its shape when no longer subject to compression or deformation forces. For example, the tip portion 202 may be made of a resilient thermoplastic elastomer plastic material, such as thermoplastic polyurethane or a polymeric or copolymeric polyether block amide, such as a PEBAX® engineering thermoplastic elastomer. The tip portion 202 may also be made of a flexible metal material that may be compressed or re-shaped by extending the tip portion 202 to straighten the tip portion 202 along a longitudinal axis of the catheter member 204, such as a shaped nitinol metal. When the tip portion 202 is uncompressed, the tip portion 202 reverts back to its uncompressed shape. If desired, the metal tip portion 202 may be coated or covered with a jacket plastic material, such that the tip portion 202 may remain or be enhanced to be compressible and resilient when the compression force is released.


The tip portion 108 (and corresponding parts of the various embodiments) of the catheter systems 100 (and corresponding parts of the various embodiments), have a very soft, atraumatic tip to prevent the tip from perforating or tearing the blood vessel into which inserted as it is advanced through the blood vessel. Catheter shafts, in general, need to be stiffer to offer pushability and prevent buckling. Therefore the tip portion of the catheter system transitions from a relatively stiff shaft section to a very soft tip. The transition can occur in one step or over a series of steps. By way of example and not limitation, one embodiment of the catheter system 200 of the present invention (and corresponding parts of the various embodiments) has a catheter member 204, made of a PEBAX® polymer with a 72 durometer (D) hardness, with a coaxial nitinol hypotube running down the central lumen 222. This catheter member is rather stiff to have good pushability and also withstand aortic occlusion. The nitinol hypotube terminates just distal of any expansible members, such as a balloon that may be carried by the catheter system, but the catheter member still is a PEBAX® polymer with a 72 D hardness. The catheter tip portion 202 is softer, and has a significantly lower hardness, such as 40 D, but may also be made of a PEBAX® polymer to make the tip atraumatic. Some catheter systems transition from high durometers of the catheter member 204 to tip portions 204 having lower durometers over multiple steps (e.g. 72 D, 60 D, 55 D, 40 D, 35 D, etc), usually depending on the rest of the catheter design.


Additionally, it is often helpful to transition from a catheter member 204 made of a PEBAX® polymer as a tubular member with a hardness of 72 D to a solid tip portion 202 made of a PEBAX® polymer with a hardness of 40 D. If the tip portion, even if made of a PEBAX® polymer with a hardness of 40 D were a tube, rather than a solid, it may not function as well, since it may collapse, kink, be too flimsy, etc. However, the hardness of the tip portion can be adjusted to be an atraumatic tip based on the construction of the tip portion, its shape, whether it is tubular or solid, or the like, in view of the description herein.


To prepare for insertion into the patient's vascular system, by means of an introducer sheath, the tip portion 202 may be straightened in a compressed state to ease insertion into the valve of the introducer sheath. Introducer sheaths are commonly used to provide access to blood vessels, such as the femoral artery, and often have a hemostasis valve to minimize blood loss. A peel-away sheath insertion tool can be used to straighten the tip portion 202 into a compressed state to ease insertion of the catheter tip past the introducer sheath valve. A peel-away sheath is often comprised of a plastic tube that can be peeled apart after assisting the insertion of the catheter into the introducer sheath to separate it from the catheter. Once the tip portion 202 exits the introducer sheath, it may automatically re-shape to its shape in an uncompressed or undeformed state as shown in FIG. 2A. The shape of the tip portion 202 may be used as a guide to ensure that the catheter is following the desired path through the blood vessels.


It is noted that the tip portion 202 of the catheter guiding tip 200 in the examples illustrated in FIGS. 2A-2G is attached to a distal end of the catheter member 204. In other example implementations, the catheter guiding tip 200 may be formed as an extension of the catheter member 204. The tip portion 202 in the examples illustrated in FIGS. 2A-2G also has a solid core. The tip portion 202 in other example implementations may include a lumen or a hollow core to provide further pliability if so desired. The tip portion 202 of the catheter guiding tip 200 in the examples in FIGS. 2A-2G is also shaped as a curled, or coiled member. However, the tip portion in other example implementations may have any suitable shape that expands to a size greater than the outer dimension of the catheter member and sufficient to enter larger blood vessels such as the aorta, and not smaller blood vessels.



FIGS. 3A-3C are different views of another example catheter guiding tip 300. The catheter guiding tip 300 includes a tip portion 302 extending from a catheter member (not shown). The top portion 302 extends along a catheter connection portion 303 to a transition section 304 where the tip portion 302 expands in size to form a bulbous section 306. The bulbous section 306 of the tip portion 302 has a shape with an overall outer dimension in an undeformed state that is larger along axis A, which is perpendicular to a longitudinal axis of the catheter member, than the outer dimension of the catheter member. The tip portion 302 extends distally from the bulbous section 306 to a distal tubular extension 308. As shown in FIG. 3C, the catheter connection portion 303 of the tip portion 302 includes an inner space 310 extending longitudinally towards the bulbous section 306, which also includes a tip portion inner space 312. The inner space 310 and the tip portion inner space 312 allow the catheter connection portion 303 and tip portion 302 to be supple and resilient so the catheter guiding tip 300 is deformable and resumes its bulbous shape when not subject to compressing forces. The suppleness and resilience of the tip portion 302 may depend on the properties of the material of which the tip portion 302 is made and on the dimension between the outer surface of the tip portion 302 and the inner surface of the tip portion inner space 312.



FIGS. 4A-4C are different views of another example catheter guiding tip 400. The catheter guiding tip 400 includes a tip portion 402 extending from a catheter member (not shown) along a catheter connection portion 408. The tip portion 402 has a bulbous shape 404 similar to that of the tip portion 302 in the catheter guiding tip 300 in FIGS. 3A-3C. The tip portion 402 extends distally from the bulbous shape 404 to a distal solid or tubular extension 406. The catheter connection portion 408 may extend to and through the bulbous shape 404 of the tip portion 402 with a catheter inner space 410 extending through the catheter connection portion 408. It is noted that the catheter connection portion 408 may be a solid or tubular section of the tip portion 402 that connects to a distal end of the catheter member as described above with reference to FIGS. 2A-2G. Alternatively, the catheter connection portion 408 and the tip portion 402 may be an extension of the catheter member.


The bulbous shape 404 of the tip portion 402 may include a space filler 412 in the inner space of the bulbous shape 404. The space filler 412 may be made of foam, porous plastic or any other suitable compressible material and may be formed unitarily with the bulbous shape 404 or separately inserted or attached within the bulbous shape. In an example embodiment, the inner space of the bulbous shape 404 may simply be air.



FIGS. 5A-5C are different views of another example catheter guiding tip 500. The catheter guiding tip 500 includes a tip portion 502 extending from catheter connection portion 508 of the tip portion 502. The catheter connection portion 508 may attach to a catheter member (not shown) as described above with reference to FIGS. 2A-2G. The tip portion 502 has a bulbous shape 504 similar to that of the tip portion 402 in the catheter guiding tip 400 in FIGS. 4A-4C except that the tip portion 502 does not have a tubular extension like tubular extensions 308 or 406 of FIGS. 3A-3C or FIGS. 4A-4C, respectively, that extends distally from the bulbous shape 504. The catheter connection portion 508 extends to a transition section 506 that connects the bulbous shape 504 of the tip portion 702 to the catheter connection portion 508. The catheter connection portion 508 has a catheter inner space 510 extending through the length of the catheter connection portion 508. The transition section 506 is a section with an outer dimension greater than the outer dimension of the catheter connection member 508, providing a stiffness in the transition between the straight catheter connection portion 508 and the bulbous shape 504. The bulbous shape 504 has a tip portion inner space 512 to allow bulbous shape 504 of the tip portion 502 to deform when subject to compression forces. The tip portion inner space 512 may be filled with foam or other compressible material.



FIGS. 6A-6C are different views of another example catheter guiding tip 600. The catheter guiding tip 600 includes a tip portion 602 extending from a catheter connection portion 608 for connecting to a catheter member (not shown). The catheter connection portion 608 extends to a transition section 606, which expands to a bulbous shape 604 similar to that of the tip portion 502 in the catheter guiding tip 500 in FIGS. 5A-5C. The catheter connection portion 608 has a catheter inner space 610 extending through the length of the catheter connection portion 608. The transition section 606 expands into the bulbous shape 604 without any enlargement of the outer dimension of the transition section 606. The bulbous shape 604 has an inner space, which is filled in the example shown in FIG. 6C with a compressible material 612. In another example, the inner space of the bulbous shape 604 is filed with air.



FIGS. 7A-7C are different views of another example catheter guiding tip 700. The catheter guiding tip 700 is similar to the catheter guiding tip 300 in FIGS. 3A-3C. The catheter guiding tip 700 in FIGS. 7A-7C includes a catheter connection portion 702, which extends distally to a bulbous shape 704. The catheter connection portion 702 includes an inner space 706 and the bulbous shape 704 includes a tip portion inner space 708 similar to the catheter guiding tip 300 in FIGS. 3A-3C. The catheter guiding tip 700 also extends distally from the bulbous shape 704 to a distal tubular extension 712. An alignment pin 710 is fitted in the inner space 706 of the catheter connection portion 702 and extends distally through the tip portion inner space 708 into the distal tubular extension 712. The alignment pin 710 may be made of any suitable material so that the alignment pin 710 is stiffer than the bulbous shape 704. The alignment pin 710 ensures that the distal tubular extension 712 extends distally during radial compression while keeping the distal tubular extension 712 on the same axis as the catheter connection portion 702 (as well as the catheter itself). The alignment pin 710 prevents the catheter guiding tip 700 from folding on itself.



FIGS. 8A-8C are different views of another example catheter guiding tip 800. The catheter guiding tip 800 is also similar to the catheter guiding tip 300 in FIGS. 3A-3C. The catheter guiding tip 800 in FIGS. 8A-8C includes a catheter connection portion 802, which extends distally to a bulbous shape 804. The catheter connection portion 802 includes an inner space 806 and the bulbous shape 804 includes a tip portion inner space 808 similar to the catheter guiding tip 300 in FIGS. 3A-3C. The catheter guiding tip 800 also extends distally from the bulbous shape 804 to a distal solid or tubular extension 812. The bulbous shape 804 includes a bulbous shape frame 810 extending from the inner space 806 of the catheter connection portion 802 into the tip portion inner space 808 and is secured distally in the solid or distal tubular extension 812. The bulbous shape frame 810 may be made of any suitable material so that the bulbous shape frame 810 stiffens the bulbous shape 804, but yet remains compressible. The bulbous shape frame 810 ensures that the distal solid or tubular extension 812 extends distally during radial compression while keeping the distal solid or tubular extension 812 on the same axis as the catheter connection portion 802 (as well as the catheter itself). The bulbous shape frame 810 also prevents the catheter guiding tip 800 from folding on itself.



FIGS. 9A-9C are different views of another example catheter guiding tip 900. The catheter guiding tip 900 includes a tip portion 902 comprising a plurality of guiding members 904 extending radially from a solid or tubular portion 905 that extends from a catheter connection portion 908. The solid or tubular portion 905 extends beyond the at least one guiding member 904 to a distal solid or tubular tip 906. The plurality of guiding members 904 shown in FIGS. 9A-9C are substantially flattened members radiating from the solid or tubular portion 905 so that the tip portion 902 expands to a dimension T2 that is larger than the outer dimension T1 of the catheter connection portion 908 to prevent the tip portion 902 from entering smaller blood vessels as the catheter is inserted in the patient's blood vessels during deployment. The guiding members 904 are flattened perpendicular to a longitudinal axis of the catheter connection portion 908. The tip portion 902 in FIGS. 9A-9C may be made of an injection molded plastic that is compressible so that the tip portion 902 may be deformed under compression forces, yet resilient so that the tip portion 902 returns to its normal shape when compression forces are removed.



FIGS. 10A-10C are different views of another example catheter guiding tip 1000. The catheter guiding tip 1000 includes a tip portion 1002 comprising a plurality of guiding members 1004 extending radially from a solid or tubular portion 1005 that extends distally from a catheter connection portion 1008. The tubular portion 1005 extends beyond the at least one guiding member 1004 to a distal solid or tubular tip 1006. The plurality of guiding members 1004 shown in FIGS. 10A-10C are longitudinally flattened members radiating along a curve from the solid or tubular portion 1005. The guiding members 1004 in FIGS. 10A-10C extend radially as curved members as shown in FIG. 10B. However, in another embodiment, the guiding members 1004 may also extend as straight extending members. The tip portion 1002 in FIGS. 10A-10C may also be made of an injection molded plastic that is compressible.



FIGS. 11A-11C are different views of another example catheter guiding tip 1100. The catheter guiding tip 1100 includes a tip portion 1102 comprising a plurality of guiding members 1104 extending radially from a solid or tubular portion 1105 that extends distally from a catheter connection portion 1112. A narrowed neck portion 1107 connects the catheter connection portion 1112 to the solid or tubular portion 1105. The solid or tubular portion 1105 extends beyond the at least one guiding member 1104 to a distal solid or tubular tip 1106. The guiding members 1104 are substantially solid or tubular guiding members radiating from the tubular portion 1105 of the tip portion 1102. In the example shown in FIGS. 11A-11C, the substantially solid or tubular guiding members comprise a spherical tip 1110 to provide a less traumatic structure moving through the patient's blood vessels.



FIGS. 12A-12C are different views of another example catheter guiding tip 1200. The catheter guiding tip 1200 includes a tip portion 1202 comprising a plurality of guiding members 1204 extending radially from a solid or tubular portion 1205 that extends distally from a catheter connection portion 1210. The solid or tubular portion 1205 extends beyond the at least one guiding member 1204 to a distal tubular tip 1208. The guiding members 1204 in FIGS. 12A-12C extend longitudinally and radially outward from the solid or tubular portion 1205 then radially inward to connect back to the solid or tubular portion 1205. The plurality of guiding members 1204 in FIGS. 12A-12C substantially form a bulbous shaped frame having a size that prevents the tip portion 1202 from entering smaller blood vessels during deployment of the catheter.



FIGS. 13A-13C are different views of another example catheter guiding tip 1300. The catheter guiding tip 1300 includes a tip portion 1302 comprising a first plurality of guiding members 1306 and a second plurality of guiding members 1304 extending radially from a solid or tubular portion 1305 that extends distally from a catheter connection portion 1310. The second plurality of guiding members 1304 extends radially from the solid or tubular portion 1305 at a point distal to the first plurality of guiding members 1306 and proximal to a distal solid or tubular tip 1308 at a distal end of the solid or tubular portion 1305. The first plurality of guiding members 1306 and the second plurality of guiding members 1304 are flattened perpendicular to the longitudinal axis of the catheter connection portion 110. The first plurality of guiding members 1306 extends from the solid or tubular portion 1305 at an angular shift relative to the second plurality of guiding members 1304. In the example shown in FIGS. 13A-13C, the four first guiding members 1306 extend at 90° from one another. The four second guiding members 1304 extend at 90° from one another and at 45° relative to the four first guiding members 1306.



FIGS. 14A-14C are different views of another example catheter guiding tip 1400. The catheter guiding tip 1400 includes a tip portion 1402 comprising a first plurality of guiding members 1406 and a second plurality of guiding members 1404 extending radially from a catheter extension 1405 that extends distally from a catheter connection portion 1412. The second plurality of guiding members 1404 extends radially from the solid or tubular portion 1405 at a distal end of the catheter extension 1405. The first plurality of guiding members 1406 extends from the catheter extension 1405 at a point proximal to the second plurality of guiding members 1404. The first plurality of guiding members 1406 and the second plurality of guiding members 1404 are flattened perpendicular to the longitudinal axis of the catheter member 1412. The first plurality of guiding members 1406 extend from the catheter extension 1405 at an angular shift relative to the second plurality of guiding members 1404. In the example shown in FIGS. 14A-14C, the two first guiding members 1406 extend at 180° from one another. The two second guiding members 1404 extend at 180° from one another and at 90° relative to the two first guiding members 1406.



FIGS. 15A-15C are different views of another example catheter guiding tip 1500. The catheter guiding tip 1500 includes a tip portion 1502 at a distal tip 1506 of a catheter connection portion 1508. The tip portion 1502 is a hemisphere shape 1504 extending proximally from the distal tip 1506 at the most distal point of the tip portion 1502. The hemisphere shape 1504 preferably is a hollow hemisphere 1510 so that the tip portion 1502 is more easily compressible.


The foregoing description of implementations has been presented for purposes of illustration and description. It is not exhaustive and does not limit the claimed inventions to the precise form disclosed. Modifications and variations are possible in light of the above description or may be acquired from practicing the invention. The claims and their equivalents define the scope of the invention.

Claims
  • 1. A device for guiding a catheter through a patient's blood vessels comprising: a catheter guiding tip extending distally at a distal end of the catheter with an outer dimension substantially the same as an outer dimension of the catheter, the catheter guiding tip expanding distally to at least one guiding member with a tip portion having a shape in an uncompressed state that is larger than the catheter outer dimension along at least one axis perpendicular to a longitudinal axis of the catheter, the catheter guiding tip portion being deformable for insertion in a sheath larger than the tip portion when the tip portion is compressed but smaller than the tip portion when the tip portion is not compressed and resilient for resuming the shape in the uncompressed shape when not subject to compression forces, wherein the shape of the tip portion in the uncompressed state is formed as a member extending distally and radially to form a substantially hook-shaped member along an axis perpendicular to the longitudinal axis of the catheter, and the tip portion transitions to a flattened cross-section as the tip portion hooks around to the most distal point of the tip portion.
  • 2. The device of claim 1, wherein the tip portion hooks circularly around such that a most distal point of the tip portion is positioned near a transition point where the catheter begins to extend radially to form the tip portion.
  • 3. The device of claim 1, wherein the tip portion hooks circularly around such that a most distal point of the tip portion is positioned distal to a transition point where the catheter begins to extend radially to form the tip portion so that the tip portion spirals inward.
  • 4. The device of claim 1, wherein the tip portion is one of a solid member or a tubular member.
  • 5. The device of claim 1, wherein the tip portion is formed by injection molded plastic.
  • 6. The device of claim 1, wherein the tip portion comprises a pre-shaped nitinol member.
  • 7. The device of claim 6, wherein the catheter is a nitinol wire and the tip portion is formed as an extension of a nitinol wire.
  • 8. The device of claim 1, wherein the tip portion is formed as an extension of the catheter.
  • 9. A device for guiding a catheter through a patient's blood vessels comprising: a catheter guiding tip extending distally at a distal end of the catheter with an outer dimension substantially the same as an outer dimension of the catheter, the catheter guiding tip expanding distally to at least one guiding member with a tip portion having a shape in an uncompressed state that is larger than the catheter outer dimension along at least one axis perpendicular to a longitudinal axis of the catheter, the catheter guiding tip portion being deformable for insertion in a sheath larger than the tip portion when the tip portion is compressed but smaller than the tip portion when the tip portion is not compressed and resilient for resuming the shape in the uncompressed shape when not subject to compression forces, wherein the tip portion comprises a first plurality of guiding members extending radially from a portion that extends beyond the at least one guiding member to a distal extension, and a second plurality of guiding members extending radially from the portion from which the guiding members extend at a point distal to the first plurality of guiding members and proximal to the distal tubular extension.
  • 10. The device of claim 9, wherein the first and second plurality of guiding members are substantially flattened members radiating from the portion from which the respective guiding members extend.
  • 11. The device of claim 10, wherein the first and second plurality of guiding members are flattened longitudinally along the portion from which the respective guiding members extend.
  • 12. The device of claim 10, wherein the first and second plurality of guiding members are flattened perpendicular to the longitudinal axis of the catheter.
  • 13. The device of claim 9, wherein the first and second guiding members are substantially tubular guiding members extending radially from a tubular portion of the tip portion from which the respective guiding members extend.
CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is a national stage application under 35 U.S.C. § 371 of International Patent Application No. PCT/US2015/035061, filed Jun. 10, 2015 and titled, “Conduit Guiding Tip,” which was published under International Publication No. WO 2015/191685 A1 and claims the benefit of U.S. Provisional Patent Application No. 62/010,297, filed on Jun. 10, 2014 titled, “Conduit Guiding Tip,” the disclosures of which are incorporated herein by reference.

STATEMENT REGARDING FEDERALLY SPONSORED RESEARCH OR DEVELOPMENT

This invention was made with government support under Contract No. W81XWH-12-1-0558 awarded by U.S. Army Medical Research Materiel Command. The government has certain rights in the invention.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2015/035061 6/10/2015 WO 00
Publishing Document Publishing Date Country Kind
WO2015/191685 12/17/2015 WO A
US Referenced Citations (140)
Number Name Date Kind
2156289 Hoy May 1939 A
4464172 Lichtenstein Aug 1984 A
4713888 Broselow Dec 1987 A
4777951 Cribier et al. Oct 1988 A
4823469 Broselow Apr 1989 A
4865549 Sonsteby Sep 1989 A
4926885 Hinkle May 1990 A
4983166 Yamawaki Jan 1991 A
5135494 Engelson et al. Aug 1992 A
5169386 Becker et al. Dec 1992 A
5282479 Havran Feb 1994 A
5320605 Sahota Jun 1994 A
5383856 Bersin Jan 1995 A
5447503 Miller Sep 1995 A
5505702 Arney Apr 1996 A
5522400 Williams Jun 1996 A
5571093 Cruz et al. Nov 1996 A
5718678 Fleming, III Feb 1998 A
5738652 Boyd et al. Apr 1998 A
5911702 Romley et al. Jun 1999 A
6011988 Lynch et al. Jan 2000 A
6013019 Fischell et al. Jan 2000 A
6102930 Simmons, Jr. Aug 2000 A
6113579 Eidenschink et al. Sep 2000 A
6146370 Barbut Nov 2000 A
6161547 Barbut Dec 2000 A
6165199 Barbut Dec 2000 A
6190356 Bersin Feb 2001 B1
6231572 Hart et al. May 2001 B1
6248121 Nobles Jun 2001 B1
6280434 Kinoshita Aug 2001 B1
6423031 Donlon Jul 2002 B1
6453572 Cross et al. Sep 2002 B2
6575932 O'Brien et al. Jun 2003 B1
6579221 Peterson Jun 2003 B1
6602270 Leschinsky et al. Aug 2003 B2
6656153 Sakai et al. Dec 2003 B1
6666814 Downey et al. Dec 2003 B2
6669679 Savage et al. Dec 2003 B1
6679860 Stiger Jan 2004 B2
6695811 Samson et al. Feb 2004 B2
6719270 Ozawa Apr 2004 B2
6719720 Voelker et al. Apr 2004 B1
6733513 Boyle et al. May 2004 B2
6735532 Freed et al. May 2004 B2
6736790 Barbut et al. May 2004 B2
6746462 Selmon Jun 2004 B1
6796959 Davis et al. Sep 2004 B2
6936056 Nash et al. Aug 2005 B2
6979318 McDonald et al. Dec 2005 B1
7341571 Harris et al. Mar 2008 B1
7434326 Gifford Oct 2008 B2
7503904 Choi Mar 2009 B2
7503909 Kusu et al. Mar 2009 B2
7763043 Goodin et al. Jul 2010 B2
7892469 Lim et al. Feb 2011 B2
7909810 Noone Mar 2011 B2
7951186 Eidenschink et al. May 2011 B2
7951819 Niculescu-Duvaz et al. May 2011 B2
7959644 Shriver Jun 2011 B2
8088103 Teeslink et al. Jan 2012 B2
8162879 Hattangadi et al. Apr 2012 B2
8241241 Evans et al. Aug 2012 B2
8262611 Teeslink et al. Sep 2012 B2
8419648 Corl et al. Apr 2013 B2
8430899 Dae et al. Apr 2013 B2
8499681 Kanner et al. Aug 2013 B2
8545382 Suzuki et al. Oct 2013 B2
8655798 Humphrey et al. Feb 2014 B2
8672868 Simons Mar 2014 B2
8747358 Trombley, III et al. Jun 2014 B2
8814900 Fleming, III Aug 2014 B2
8900214 Nance et al. Dec 2014 B2
8948848 Merhi Feb 2015 B2
8951565 McCarthy Feb 2015 B2
9131874 Eliason et al. Sep 2015 B2
D748257 Franklin Jan 2016 S
9414843 Pavcnik et al. Aug 2016 B2
9474882 Franklin Oct 2016 B2
9687333 Angel et al. Jun 2017 B2
20020193735 Stiger Dec 2002 A1
20030032974 Leschinsky et al. Feb 2003 A1
20030167038 Yozu et al. Sep 2003 A1
20040073162 Bleam et al. Apr 2004 A1
20040082935 Lee et al. Apr 2004 A1
20040254528 Adams et al. Dec 2004 A1
20050059931 Garrison et al. Mar 2005 A1
20050148812 Nigroni et al. Jul 2005 A1
20050261725 Crawford et al. Nov 2005 A1
20070043307 Raulerson et al. Feb 2007 A1
20070043409 Brian et al. Feb 2007 A1
20070129466 Kagawa et al. Jun 2007 A1
20070135830 Schaeffer Jun 2007 A1
20070219466 Tremulis et al. Sep 2007 A1
20070219488 Francescatti Sep 2007 A1
20080027356 Chen et al. Jan 2008 A1
20080082046 Kato et al. Apr 2008 A1
20080082119 Vitullo Apr 2008 A1
20080243067 Rottenberg et al. Oct 2008 A1
20080262477 Djaladat Oct 2008 A1
20090026595 Kadoi Jan 2009 A1
20090062666 Roteliuk Mar 2009 A1
20090171272 Tegg et al. Jul 2009 A1
20090171293 Yang et al. Jul 2009 A1
20090265951 Black Oct 2009 A1
20090287079 Shriver Nov 2009 A1
20090312807 Boudreault et al. Dec 2009 A1
20100016735 Harpas et al. Jan 2010 A1
20100041984 Shapland et al. Feb 2010 A1
20100234915 Herlich et al. Sep 2010 A1
20100262076 Rowe et al. Oct 2010 A1
20100268017 Siess Oct 2010 A1
20100280451 Teeslink et al. Nov 2010 A1
20110196412 Levit et al. Aug 2011 A1
20110295301 Hoem et al. Dec 2011 A1
20110295302 Mohl Dec 2011 A1
20110301630 Hendriksen et al. Dec 2011 A1
20120101413 Beetel et al. Apr 2012 A1
20120108979 Franklin et al. May 2012 A1
20120109057 Krolik et al. May 2012 A1
20120116352 Rangi May 2012 A1
20120130359 Turovskiy May 2012 A1
20120172911 Welch Jul 2012 A1
20120215166 Barki Aug 2012 A1
20120271231 Agrawal Oct 2012 A1
20120302994 Wilson et al. Nov 2012 A1
20130102926 Eliason et al. Apr 2013 A1
20130102929 Haight et al. Apr 2013 A1
20130190619 Nudel Jul 2013 A1
20130281869 Barbut et al. Oct 2013 A1
20130289607 Pedersen et al. Oct 2013 A1
20140221898 Kurrus et al. Aug 2014 A1
20140243873 Franklin Aug 2014 A1
20140249504 Franklin et al. Sep 2014 A1
20140316012 Freyman et al. Oct 2014 A1
20140378869 Sela et al. Dec 2014 A1
20150012031 Rago et al. Jan 2015 A1
20150039012 Solar et al. Feb 2015 A1
20150367098 Aggerholm et al. Dec 2015 A1
20160000446 Eliason et al. Jan 2016 A1
Foreign Referenced Citations (33)
Number Date Country
1094861 Apr 2005 EP
1658808 May 2006 EP
1911484 Apr 2008 EP
2389974 Nov 2011 EP
2716323 Apr 2014 EP
2297259 Jul 1996 GB
H 03198868 Aug 1991 JP
H 09-164208 Jun 1997 JP
2002505165 Feb 2002 JP
2003535652 Dec 2003 JP
200714820 Jan 2007 JP
2008546471 Dec 2008 JP
2011245300 Dec 2011 JP
9220398 Nov 1992 WO
9713542 Apr 1997 WO
9834670 Aug 1998 WO
199924105 May 1999 WO
9944666 Sep 1999 WO
0197743 Dec 2001 WO
2004049970 Jun 2004 WO
2006135853 Dec 2006 WO
2007001701 Jan 2007 WO
2007022592 Mar 2007 WO
2008013441 Jan 2008 WO
2010070685 Jun 2010 WO
2011133736 Oct 2011 WO
2014003809 Jan 2014 WO
2014134215 Sep 2014 WO
2014152191 Sep 2014 WO
2015006828 Jan 2015 WO
2015035393 Mar 2015 WO
2015191685 Dec 2015 WO
2016149653 Sep 2016 WO
Non-Patent Literature Citations (39)
Entry
Extended European Search Report dated Jun. 26, 2017 in EP Application No. 14842370.
Int'l Preliminary Report dated Jul. 17, 2017 in Int'l Application No. PCT/US2016/023223.
Int'l Search Report and Written Opinioin dated Sep. 28, 2017 in Int'l Application No. PCT/US2017/035729.
Office Action dated Sep. 19, 2017 in JP Application No. 2015-559309.
Office Action dated Sep. 12, 2017 in JP Application No. 2016-546035.
Office Action dated Oct. 12, 2017 in CA Application No. 2,980,018.
Holcomb et al., “Causes of death in US Special Operations Forces in the global war on terrorism: 2001-2004,” Annals of Surgery, vol. 245, No. 6, pp. 986-991 (2007).
Sohn et al., “Demographics, Treatment, and Early Outcomes in Penetrating Vascular Combat Trauma,” Arch Surg, vol. 143, No. 8, pp. 783-787 (2008).
White et al., “The Epidemiology of Vascular Injury in the Wars in Iraq and Afghanistan,” Annals of Surgery, vol. 253, No. 6, pp. 1184-1189.
Fenton et al., “Comparing risks of alternative medical diagnosis using Bayesian arguments,” J. Biomed. Inf., vol. 43, pp. 485-495 (2010).
Patel et al., “Bayesian Designs for Device Clinical Trials,” MDG Forum, Waltham, MA., Nov. 3, 2010, downloaded from web page: <http://www.cytel.com/pdfs/Patel_Bayes_Devices_Slides_11.18.10.pdf>.
Guidance for the Use of Bayesian Statistics in Medical Device Clinical Trials, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Devices and Radiological Health, Division of Biostatistics, Office of Surveillance and Biometrics, Feb. 5, 2010.
Int'l Preliminary Report on Patentability dated Sep. 11, 2015 in Int'l Application No. PCT/US2014/018779.
Int'l Search Report and Written Opinion dated Jun. 8, 2014 in Int'l Application No. PCT/US2014/018779.
Int'l Search Report and Written Opinion dated Oct. 14, 2011 in Int'l Application No. PCT/US2011/033368.
Sandgren et al., “The Diameter of the Common Femoral Artery in Healthy Human: Influence of Sex, Age, and Body Size,” Journal of Vascular Surgery, vol. 29, No. 3, pp. 503-510 (1999).
Sam II et al., “Blunt Traumatic Aortic Transection: Endoluminal Repair with Commercially Available Aortic Cuffs,” Journal of Vascular Surgery, vol. 38, No. 5, pp. 1132-1135 (2003).
Peterson et al., “Percutaneous endovascular repair of blunt thoracic aortic transection,” Journal of Trauma, vol. 59, No. 5, pp. 1062-1065 (2005).
Office Action dated Oct. 28, 2014 in U.S. Appl. No. 13/642,465.
Office Action dated Apr. 6, 2015 in U.S. Appl. No. 13/642,465.
Stannard et al., “Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) as an Adjunct for Hemorrhagic Shock,” J. Trauma, vol. 71, pp. 1869-1872 (2011).
Ledgerwood et al., “The Role of Thoracic Aortic Occlusion for Massive Hemoperitoneum,” J Trauma, vol. 16, No. 8, pp. 610-615 (1976).
Detrano et al. “Bayesian Probability Analysis: a Prospective Demonstration of its Clinical Utility in Diagnosing Coronary Disease,” Circulation, vol. 69, No. 3, pp. 541-547 (1984).
Int'l Search Report and Written Opinion dated Jan. 28, 2015 in Int'l Application No. PCT/US2014/054802.
Int'l Preliminary Report on Patentability dated Mar. 24, 2016 in Int'l Application No. PCT/US2014/054802.
Int'l Preliminary Report on Patentability dated Nov. 1, 2012 in Int'l Application No. PCT/US2011/033368.
Langewouters et al., “The static elastic properties of 45 human thoracic and 20 abdominal aortas in vitra and the parameters of a new model,” Journal of Biometrics, vol. 17, No. 6, pp. 425-435 (1984).
Hughes, “Use of an Intra-Aortic Balloon Catheter Tamponade for Controlling Intra-Abdominal Hemorrhage in Man,” Surgery, vol. 36, pp. 65-68 (1954).
Office Action dated Aug. 23, 2016 in AU Application No. 2015274743.
Extended European Search Report dated Oct. 5, 2016 in Europe Application No. EP 14 75 6640.
Supplemental Search Report dated Dec. 19, 2016 in EP Application No. 15806534.
Int'l Preliminary Report dated Dec. 22, 2016 in Int'l Application No. PCT/US2015/035061.
Int'l Search Report and Written Opinion dated Sep. 4, 2015 in Int'l Application No. PCT/US2014/035061.
Extended Search Report dated Mar. 24, 2017 in EP Application No. 14842370.
Int'l Search Report and Written Opinion dated Apr. 21, 2017 in Int'l Application No. PCT/US2016/023223.
Extended Search Report dated Mar. 21, 2017 in EP Application No. 15806534.
Office Action dated Apr. 11, 2017 in JP Application No. 2016-546035.
Office Action dated Mar. 20, 2017 in CA Application No. 2,797,237.
Chen et al., “The Renal Length Nomogram: A Multivariable Approach,” The Journal of Urology, vol. 168, pp. 2149-2152 (Nov. 2002).
Related Publications (1)
Number Date Country
20170043123 A1 Feb 2017 US
Provisional Applications (1)
Number Date Country
62010297 Jun 2014 US